UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-38344

METAURUS EQUITY COMPONENT TRUST

(Exact Name of Registrant as Specified in its Charter)

Delaware		35-2594229 30-0987130
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

c/o Metaurus Advisors LLC 589 Fifth Avenue, Suite 808 New York, New York		10017
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (201) 683-7979

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☐
		Emerging Growth Company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Shares of U.S. Equity Cumulative Dividends Fund – Series 2027	IDIV	NYSE Arca, Inc.
Shares of U.S. Equity Ex-Dividend Fund – Series 2027	XDIV	NYSE Arca, Inc.

As of October 22, 2021, the Registrant had 3,870,000 shares outstanding.

Table of Contents

		Page
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements	1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	30
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	32
Item 4.	Controls and Procedures	32
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	33
Item 1A.	Risk Factors	33
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	33
Item 3.	Defaults Upon Senior Securities	33
Item 4.	Mine Safety Disclosures	33
Item 5.	Other Information	34
Item 6.	Exhibits	34
Signatures		35

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

Index

Documents

Statements of Financial Condition, Schedules of Investments, Statements of Operations, Statements of Changes in Shareholders’ Equity and Statements of Cash Flows:

U.S. Equity Cumulative Dividends Fund—Series 2027
Statements of Financial Condition as of September 30, 2021 (unaudited) and December 31, 2020 (audited)		2
Schedules of Investments as of September 30, 2021 (unaudited) and December 31, 2020 (audited)		3
Statements of Operations for the Three and Nine Months Ended September 30, 2021 and 2020 (unaudited)		5
Statements of Changes in Shareholders’ Equity for the Nine Months Ended September 30, 2021 and 2020 (unaudited)		6
Statements of Cash Flows for the Nine Months Ended September 30, 2021 and 2020 (unaudited)		7
U.S. Equity Ex-Dividend Fund—Series 2027
Statements of Financial Condition as of September 30, 2021 (unaudited) and December 31, 2020 (audited)		8
Schedules of Investments as of September 30, 2021 (unaudited) and December 31, 2020 (audited)		9
Statements of Operations for the Three and Nine Months Ended September 30, 2021 and 2020 (unaudited)		11
Statements of Changes in Shareholders’ Equity for the Nine Months Ended September 30, 2021 and 2020 (unaudited)		12
Statements of Cash Flows for the Nine Months Ended September 30, 2021 and 2020 (unaudited)		13
Notes to Unaudited Financial Statements		14

U.S. Equity Cumulative Dividends Fund—Series 2027

Statements of Financial Condition

	September 30, 2021 (Unaudited)		December 31, 2020
Assets
Investments, at Fair Value (Cost $30,708,977 and $18,746,186, respectively)	$	30,449,028	$	18,835,724
Cash and Cash Equivalents		469,596		349,052
Cash Pledged as Collateral on Futures Contracts		611,812		739,428
Interest Receivable		214,287		29,704
Variation Margin Receivable on Open Futures Contracts		-		31,500
Total Assets	$	31,744,723	$	19,985,408

Liabilities
Due to Advisor		21,084		14,405
Variation Margin Payable on Open Futures Contracts		92,000		26,250
Income Distribution Payable		376,000		231,000
Total Liabilities	$	489,084	$	271,655

Shareholders’ Equity
Authorized Participants (3,200,000 Shares and 2,100,000 Shares Outstanding, respectively)	$	31,255,639	$	19,713,753
Net Asset Value Per Share	$	9.77	$	9.39
Market Price Per Share	$	10.57	$	10.08

See accompanying notes to financial statements.

U.S. Equity Cumulative Dividends Fund—Series 2027

Schedule of Investments

September 30, 2021 (Unaudited)

Description	Principal Amount		Value
U.S. TREASURY OBLIGATIONS - 97.4%
U.S. Treasury Notes
2.250%, 11/15/2027 (1)	$	5,136,000	$	5,461,213
2.250%, 12/31/2023 (1)		4,509,000		4,701,689
2.250%, 11/15/2024 (1)		4,731,000		4,981,041
2.250%, 11/15/2025 (1)		4,874,000		5,156,730
2.125%, 12/31/2022 (1)		4,241,000		4,346,363
2.000%, 12/31/2021 (1)		536,000		538,593
2.000%, 11/15/2026 (1)		5,015,000		5,263,399

Total U.S. Treasury Obligations (Cost $30,708,977)				30,449,028

Total Investments - 97.4% (Cost $30,708,977)			$	30,449,028

Percentages are based on net assets of $31,255,639

A list of the open futures contracts held by the Fund at September 30, 2021, is as follows:

	Number of							Unrealized
	Contracts		Expiration	Notional		Notional		Appreciation
Type of Contract	Long		Date	Amount		Value		(Depreciation)
S&P 500 Annl Div Dec21		320	12/20/2021		4,804,422		4,768,000	$	(36,422	)
S&P 500 Annl Div Dec22		320	12/19/2022		4,926,422		5,060,000	$	133,578
S&P 500 Annl Div Dec23		320	12/18/2023		5,027,485		5,212,000	$	184,515
S&P 500 Annl Div Dec24		320	12/23/2024		5,103,610		5,288,000	$	184,390
S&P 500 Annl Div Dec25		320	12/22/2025		5,184,797		5,340,000	$	155,203
S&P 500 Annl Div Dec26		320	12/21/2026		5,275,110		5,376,000	$	100,890
S&P 500 Annl Div Dec27		320	12/20/2027		5,356,734		5,428,000	$	71,266

Net Unrealized Appreciation (Depreciation)								$	793,420

(1)

Security, or a portion of, has been pledged as collateral for the trading of futures contracts. The market value of the securities pledged as collateral for the period ended September 30, 2021 was $10,237,069 or 32.8% of net assets.

See accompanying notes to financial statements.

U.S. Equity Cumulative Dividends Fund—Series 2027

Schedule of Investments

December 31, 2020 (Audited)

Description	Principal Amount		Value
U.S. TREASURY OBLIGATIONS - 95.5%
U.S. Treasury Notes
2.250%, 11/15/2027 (1)	$	2,650,000	$	2,941,655
2.250%, 12/31/2023 (1)		2,441,000		2,593,372
2.250%, 11/15/2024 (1)		2,541,000		2,737,729
2.250%, 11/15/2025 (1)		2,532,000		2,765,122
2.125%, 12/31/2022 (1)		2,438,000		2,535,139
2.000%, 12/31/2021 (1)		2,403,000		2,448,109
2.000%, 11/15/2026 (1)		2,586,000		2,814,598

Total U.S. Treasury Obligations (Cost $18,746,186)				18,835,724

Total Investments - 95.5% (Cost $18,746,186)			$	18,835,724

Percentages are based on net assets of $19,713,753.

A list of the open futures contracts held by the Fund at December 31, 2020, is as follows:

	Number of							Unrealized
	Contracts		Expiration	Notional		Notional		Appreciation
Type of Contract	Long (Short)		Date	Amount		Value		(Depreciation)
S&P 500 Annl Div Dec21		210	12/20/2021		3,175,483		2,955,750	$	(219,733	)
S&P 500 Annl Div Dec22		210	12/19/2022		3,232,545		2,942,625	$	(289,920	)
S&P 500 Annl Div Dec23		210	12/18/2023		3,287,608		2,942,625	$	(344,983	)
S&P 500 Annl Div Dec24		210	12/23/2024		3,344,545		2,932,125	$	(412,420	)
S&P 500 Annl Div Dec25		210	12/22/2025		3,414,608		2,924,250	$	(490,358	)
S&P 500 Annl Div Dec26		210	12/21/2026		3,485,732		2,934,750	$	(550,982	)
S&P 500 Annl Div Dec27		210	12/20/2027		3,552,170		2,945,250	$	(606,920	)

Net Unrealized Appreciation (Depreciation)								$	(2,915,316	)

(1)

Security, or a portion of, has been pledged as collateral for the trading of futures contracts. The market value of the securities pledged as collateral for the period ended December 31, 2020 was $10,797,858 or 54.8% of net assets.

See accompanying notes to financial statements.

U.S. Equity Cumulative Dividends Fund—Series 2027

Statements of Operations

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020

Investment Income
Interest Income	$	31,954		$	19,825		$	79,375		$	152,007


Expenses
Advisory Fees		61,280			41,951			160,188			132,312
Total Expenses		61,280			41,951			160,188			132,312
Net Expenses		61,280			41,951			160,188			132,312
Net Investment Income (Loss)		(29,326	)		(22,126	)		(80,813	)		19,695

Net Realized and Unrealized Gain (Loss) from Investment Activities
Net Realized Gain (Loss) on Investments		170			16,477			12,280			1,196,454
Net Realized Gain (Loss) on Futures Contracts		-			-			-			-
Net Change in Unrealized Appreciation (Depreciation) on Investments		(54,698	)		(3,258	)		(349,488	)		48,348
Net Change in Unrealized Appreciation (Depreciation) on Futures Contracts		557,150			448,437			3,708,735			(4,581,748	)
Net Realized and Unrealized Gain (Loss) on Investments		502,622			461,656			3,371,527			(3,336,946	)
Net Increase (Decrease) in Net Assets Resulting from Operations	$	473,296		$	439,530		$	3,290,714		$	(3,317,251	)

See accompanying notes to financial statements.

U.S. Equity Cumulative Dividends Fund—Series 2027

Statements of Changes in Shareholders’ Equity

(Unaudited)

	Nine Months Ended September 30,
	2021			2020
Operations:
Net Investment Income (Loss)	$	(80,813	)	$	19,695
Net Realized Gain (Loss) on Investments and Futures Contracts		12,280			1,196,454
Net Change in Unrealized Appreciation (Depreciation) on Investments and Futures Contracts		3,359,247			(4,533,400	)
Net Increase (Decrease) in Net Assets Resulting from Operations		3,290,714			(3,317,251	)

Distributions to Shareholders:
Distributions		(2,657,250	)		(2,065,375	)
Total Distributions		(2,657,250	)		(2,065,375	)

Capital Share Transactions:
Issued		10,908,422			-
Redeemed		-			-
Net Increase (Decrease) in Net Assets Resulting from Capital Share Transactions		10,908,422			-

Total Increase (Decrease) in Net Assets		11,541,886			(5,382,626	)

Net Assets:
Beginning of Period		19,713,753			24,290,529
End of Period	$	31,255,639		$	18,907,903

Capital Share Transactions:
Beginning of Period		2,100,000			2,050,000
Issued		1,100,000			-
Redeemed		-			-
Shares Outstanding from Capital Share Transactions		3,200,000			2,050,000

See accompanying notes to financial statements.

U.S. Equity Cumulative Dividends Fund—Series 2027

Statements of Cash Flows

(Unaudited)

	Nine Months Ended September 30,
	2021			2020
Cash Flows from operating activities
Net increase/(decrease) in net assets from operations	$	3,290,714		$	(3,317,251	)
Adjustments to reconcile net increase/(decrease) in net assets from operations to net cash provided by (used in) operating activities:
Purchases of investments		(14,503,816	)		(18,539,876	)
Proceeds from sale of investments		2,276,738			24,755,671
Accretion of discounts and amortization of premiums		276,566			157,357
Net realized (gain)/loss on investments		(12,280	)		(1,196,454	)
Net change in unrealized (appreciation)/depreciation on investments		349,488			(48,350	)
(Increase)/decrease in operating assets
Interest Receivable		(184,583	)		(72,100	)
Variation margin receivable on open futures contracts		31,500			-
Increase/(decrease) in operating liabilities
Due to Advisor		6,679			(4,504	)
Variation margin payable on open futures contracts		65,750			(2,563	)
Other accrued expenses		-			(86,737	)
Net cash provided by (used in) operating activities		(8,403,244	)		1,645,193

Cash Flows from financing activities
Proceeds from capital share issuances		10,908,422			-
Distributions to shareholders		(2,512,250	)		(2,157,625	)
Net cash provided by (used in) financing activities		8,396,172			(2,157,625	)

Net change in cash and cash equivalents and restricted cash		(7,072	)		(512,432	)
Cash, cash equivalents and restricted cash, beginning of period		1,088,480			1,054,845
Cash, cash equivalents and restricted cash, end of period*	$	1,081,408		$	542,413

Supplemental Disclosure of Cash Flow and Non-Cash Information:
Income Distribution Payable	$	376,000		$	215,250

Agrees to the total of “Cash and Cash equivalents” and “Cash Pledged as Collateral for Futures Contracts” balances on the Statements of Financial Condition.

See accompanying notes to financial statements.

U.S. Equity Ex-Dividend Fund—Series 2027

Statements of Financial Condition

	September 30, 2021 (Unaudited)		December 31, 2020
Assets
Investments, at Fair Value (Cost $34,899,810 and $31,389,680, respectively)	$	34,899,810	$	31,392,285
Cash and Cash Equivalents		107,365		63,285
Cash Pledged as Collateral on Futures Contracts		4,057,937		1,890,737
Variation Margin Receivable on Open Futures Contracts		11,500		251,000
Total Assets	$	39,076,612	$	33,597,307

Liabilities
Due to Advisor		19,102		16,077
Variation Margin Payable on Open Futures Contracts		520,000		6,000
Total Liabilities	$	539,102	$	22,077

Shareholders’ Equity
Authorized Participants (400,000 Shares and 400,000 Shares Outstanding, respectively)	$	38,537,510	$	33,575,230
Net Asset Value Per Share	$	96.34	$	83.94
Market Price Per Share	$	97.01	$	84.13

See accompanying notes to financial statements.

U.S. Equity Ex-Dividend Fund—Series 2027

Schedule of Investments

September 30, 2021 (Unaudited)

Description	Principal Amount		Value
U.S. TREASURY OBLIGATIONS - 90.6%
U.S. Treasury Bills (1) (2)
0.032%, 10/07/2021	$	34,900,000	$	34,899,810
Total U.S. Treasury Obligations (Cost $34,899,810)				34,899,810

Total Investments - 90.6% (Cost $34,899,810)			$	34,899,810

Percentages are based on net assets of $38,537,510.

A list of the open futures contracts held by the Fund at September 30, 2021, is as follows:

	Number of										Unrealized
	Contracts			Expiration	Notional			Notional			Appreciation
Type of Contract	Long/(Short)			Date	Amount			Value			(Depreciation)
S&P 500 Annl Div Dec21		(40	)	12/20/2021		(613,816	)		(596,000	)		17,816
S&P 500 Annl Div Dec22		(40	)	12/19/2022		(631,004	)		(632,500	)		(1,496	)
S&P 500 Annl Div Dec23		(40	)	12/18/2023		(644,691	)		(651,500	)		(6,809	)
S&P 500 Annl Div Dec24		(40	)	12/23/2024		(660,316	)		(661,000	)		(684	)
S&P 500 Annl Div Dec25		(40	)	12/22/2025		(673,566	)		(667,500	)		6,066
S&P 500 Annl Div Dec26		(40	)	12/21/2026		(687,629	)		(672,000	)		15,629
S&P 500 Annl Div Dec27		(40	)	12/20/2027		(702,317	)		(678,500	)		23,817
E-mini S&P 500 Index Dec21		200		12/20/2021		45,034,324			42,977,500			(2,056,824	)

Net Unrealized Appreciation (Depreciation)											$	(2,002,485	)

(1)

Zero coupon security. The rate reported on the Schedule of Investments is the effective yield at time of purchase.

(2)

See accompanying notes to financial statements.

U.S. Equity Ex-Dividend Fund—Series 2027

Schedule of Investments

December 31, 2020 (Audited)

Description	Principal Amount		Value
U.S. TREASURY OBLIGATIONS - 93.5%
U.S. Treasury Bills (1) (2)
0.095%, 05/06/2021	$	31,400,000	$	31,392,285
Total U.S. Treasury Obligations (Cost $31,389,680)				31,392,285

Total Investments - 93.5% (Cost $31,389,680)			$	31,392,285

Percentages are based on net assets of $33,575,230.

A list of the open futures contracts held by the Fund at December 31, 2020, is as follows:

	Number of										Unrealized
	Contracts			Expiration	Notional			Notional			Appreciation
Type of Contract	Long/(Short)			Date	Amount			Value			(Depreciation)
S&P 500 Annl Div Dec21		(40	)	12/20/2021	$	(613,816	)	$	(563,000	)	$	50,816
S&P 500 Annl Div Dec22		(40	)	12/19/2022		(631,004	)		(560,500	)		70,504
S&P 500 Annl Div Dec23		(40	)	12/18/2023		(644,691	)		(560,500	)		84,191
S&P 500 Annl Div Dec24		(40	)	12/23/2024		(660,316	)		(558,500	)		101,816
S&P 500 Annl Div Dec25		(40	)	12/22/2025		(673,566	)		(557,000	)		116,566
S&P 500 Annl Div Dec26		(40	)	12/21/2026		(687,629	)		(559,000	)		128,629
S&P 500 Annl Div Dec27		(40	)	12/20/2027		(702,317	)		(561,000	)		141,317
E-mini S&P 500 Index Mar 21		200		03/22/2021		36,811,712			37,488,000			676,288

Net Unrealized Appreciation (Depreciation)											$	1,370,127

(1)

Zero coupon security. The rate reported on the Schedule of Investments is the effective yield at time of purchase.

(2)

See accompanying notes to financial statements.

U.S. Equity Ex-Dividend Fund—Series 2027

Statements of Operations

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020

Investment Income
Interest Income (Expense)	$	(2,388	)	$	3,210		$	(3,196	)	$	107,759


Expenses
Advisory Fees		58,054			42,189			161,241			115,517
Total Expenses		58,054			42,189			161,241			115,517
Net Expenses		58,054			42,189			161,241			115,517
Net Investment Income (Loss)		(60,442	)		(38,979	)		(164,437	)		(7,758	)

Net Realized and Unrealized Gain (Loss) from Investment Activities
Net Realized Gain (Loss) on Investments		-			372			1,766			50,314
Net Realized Gain (Loss) on Futures Contracts		2,758,352			3,199,580			8,500,168			2,073,315
Net Change in Unrealized Appreciation (Depreciation) on Investments		1,186			1,926			(2,605	)		1,666
Net Change in Unrealized Appreciation (Depreciation) on Futures Contracts		(2,662,000	)		(569,004	)		(3,372,612	)		355,429
Net Realized and Unrealized Gain (Loss) on Investments		97,538			2,632,874			5,126,717			2,480,724
Net Increase (Decrease) in Net Assets Resulting from Operations	$	37,096		$	2,593,895		$	4,962,280		$	2,472,966

See accompanying notes to financial statements.

U.S. Equity Ex-Dividend Fund—Series 2027

Statements of Changes in Shareholders’ Equity

(Unaudited)

	Nine Months Ended September 30,
	2021			2020
Operations:
Net Investment Income (Loss)	$	(164,437	)	$	(7,758	)
Net Realized Gain (Loss) on Investments and Futures Contracts		8,501,934			2,123,629
Net Change in Unrealized Appreciation (Depreciation) on Investments and Futures Contracts		(3,375,217	)		357,095
Net Increase (Decrease) in Net Assets Resulting from Operations		4,962,280			2,472,966

Capital Share Transactions:
Issued		-			-
Redeemed		-			-
Net Increase (Decrease) in Net Assets Resulting from Capital Share Transactions		-			-

Total Increase (Decrease) in Net Assets		4,962,280			2,472,966

Net Assets:
Beginning of Period		33,575,230			26,941,802
End of Period	$	38,537,510		$	29,414,768

Capital Share Transactions:
Beginning of Period		400,000			400,000
Issued		-			-
Redeemed		-			-
Shares Outstanding from Capital Share Transactions		400,000			400,000

See accompanying notes to financial statements.

U.S. Equity Ex-Dividend Fund—Series 2027

Statements of Cash Flows

(Unaudited)

	Nine Months Ended September 30,
	2021			2020
Cash Flows from operating activities
Net increase/(decrease) in net assets from operations	$	4,962,280		$	2,472,966
Adjustments to reconcile net increase/(decrease) in net assets from operations to net cash provided by (used in) operating activities:
Purchases of investments		(39,394,020	)		(42,360,092	)
Proceeds from sale of investments		35,899,741			39,871,235
Accretion of discounts and amortization of premiums		(14,085	)		(118,522	)
Net realized (gain)/loss on investments		(1,766	)		(50,314	)
Net change in unrealized (appreciation)/depreciation on investments		2,605			(1,666	)
(Increase)/decrease in operating assets
Variation margin receivable on open futures contracts		239,500			(105,500	)
Increase/(decrease) in operating liabilities
Due to Advisor		3,025			979
Variation margin payable on open futures contracts		514,000			-
Other accrued expenses		-			(91,007	)
Net cash provided by (used in) operating activities		2,211,280			(381,921	)

Cash Flows from financing activities
Proceeds from capital share issuances		-			-
Net cash provided by financing activities		-			-

Net change in cash and cash equivalents and restricted cash		2,211,280			(381,921	)
Cash, cash equivalents and restricted cash, beginning of period		1,954,022			1,134,308
Cash, cash equivalents and restricted cash, end of period*	$	4,165,302		$	752,387

Agrees to the total of “Cash and Cash equivalents” and “Cash Pledged as Collateral for Futures Contracts” balances on the Statements of Financial Condition.

See accompanying notes to financial statements.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

NOTE 1 – ORGANIZATION

Metaurus Equity Component Trust (the “Trust”) was formed in September 2016 and is authorized to have multiple series or portfolios. The Trust is a statutory trust formed under the laws of the state of Delaware. The Trust currently has two series or funds traded on the NYSE Arca, Inc. exchange (“NYSE Arca”), U.S. Equity Cumulative Dividends Fund–Series 2027 (the “Dividend Fund”) and U.S. Equity Ex-Dividend Fund–Series 2027 (the “Ex-Dividend Fund”, each a “Fund” or “ETF”, collectively the “Funds” or “ETFs”). Metaurus Advisors LLC (the “Sponsor” or “Advisor”) serves as the sponsor, commodity pool operator and commodity trading advisor of each Fund. Each of the Funds commenced operations on January 17, 2018 and commenced investment operations on February 5, 2018.

The Trust has had no investment operations prior to February 5, 2018 other than matters relating to its organization, the registration of each series/Fund under the Securities Act of 1933, as amended, and matters relating to their establishment and the capital contribution by the Sponsor of $1,000 to each Fund on December 22, 2017.

The investment objective of the ETFs is to employ a passive management, or indexing, investment approach designed to correspond to the performance of each underlying index, before fees and expenses.

Individual Shares of the ETFs may be purchased and sold only on a national securities exchange, an alternative trading system or in the over-the-counter market and not directly from the ETFs. Only broker-dealers who have entered into agreements with the Trust to act as authorized participants of the Trust (“Authorized Participants”) may purchase or redeem shares directly with the ETFs. Shares of the ETFs are listed and traded on the NYSE Arca, Inc. exchange. The Fund will issue and redeem Shares on a continuous basis, through SEI Investments Distribution Co. (the “Distributor”), at net asset value (“NAV”) per Share only in one or more large blocks of Shares, called “Baskets” as set forth in the ETFs’ current Prospectus and any prospectus supplements thereto. Baskets may be issued and redeemed for cash but are expected to be issued and redeemed principally through exchange for related positions (“EFRP”) transactions for (i) futures contracts, Treasury securities and other financial instruments designed to track such Fund’s underlying index (“Deposit Instruments”) and (ii) a cash amount that includes a variable charge. Creation and redemption prices of Baskets are directly linked to a Fund’s next computed NAV and will vary from NAV by a market-determined trading cost, which may be zero. Shares generally will trade in the secondary market in amounts less than a Basket at market prices that change throughout the day. Trading prices in the secondary market for the Shares may be different from the NAVs of the ETFs.

Undefined capitalized terms shall have the meaning as set forth in the registration statement.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Each Fund is an investment company, as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946 Financial Services — Investment Companies. As such, the ETFs follow the investment company accounting and reporting guidance.

The accompanying unaudited financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions for Form 10-Q and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

Following is a summary of the significant accounting policies followed by the Funds:

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of investment income and expenses during the reporting period. Actual results could differ from those estimates.

Concentration of Credit Risk

Credit risk is the risk that a financial loss will be incurred if a Fund’s counterparty does not fulfill its financial obligations in a timely manner. Financial instruments that potentially subject the Funds to concentrations of credit risk consist principally of investments and cash deposits. Investments and cash of each Fund at September 30, 2021 are held at Brown Brothers, Harriman & Co., and Morgan Stanley & Co. LLC.

Final Net Asset Value for Fiscal Period

The NAV per Share for a Fund is determined by dividing the net assets of the Fund by the number of outstanding Shares. The NAVs of the ETFs are determined as soon as practicable after the close of regular trading of the Shares on the NYSE Arca on each Business Day. Each Fund’s net assets on a Business Day is obtained by subtracting accrued expenses and other liabilities borne by such Fund, if any, from the total value of the assets held by the Fund, in each case, as of the time of calculation. SEI Investments Global Fund Services, Inc., the administrator of the ETFs, is responsible for calculating the NAVs.

Fair Value of Financial Instruments

Security Valuation — The Funds value investments and financial instruments at fair value. Securities listed on a securities exchange, market or automated quotation system for which quotations are readily available (except for securities traded on NASDAQ), including securities traded over the counter, are valued at the last quoted sale price on the primary exchange or market (foreign or domestic) on which they are traded (or at approximately 4:00 pm Eastern Time if a security’s primary exchange is normally open at that time), or, in the case of the futures contracts held by the Funds, at the daily settlement price published by the Chicago Mercantile Exchange for such futures contracts. For securities traded on NASDAQ, the NASDAQ Official Closing Price will be used.

Treasury Securities held by the Funds generally are priced based upon valuations provided by independent, third-party pricing agents.

Securities for which market prices are not “readily available” are valued in accordance with Fair Value Procedures established by the Sponsor or a committee of its personnel thereof. Some of the more common reasons that may necessitate that a security be valued using Fair Value Procedures include: the security’s trading has been halted or suspended; the security has been de-listed from a national exchange; the security’s primary trading market is temporarily closed at a time when under normal conditions it would be open; the security has not been traded for an extended period of time; the security’s primary pricing source is not able or willing to provide a price; or trading of the security is subject to local government-imposed restrictions. In addition, the Funds may fair value their securities if an event that may materially affect the value of a Fund’s securities that traded outside of the United States (a “Significant Event”) has occurred between the time of the security’s last close and the time that the Fund calculates its net asset value. A Significant Event may relate to a single issuer or to an entire market sector. Events that may be Significant Events include: government actions, natural disasters, armed conflict, acts of terrorism and significant market fluctuations. If the Advisor becomes aware of a Significant Event that has occurred with respect to a security or group of securities after the closing of the exchange or market on which the security or securities principally trade, but before the time at which the Fund calculates its NAV, it may request that a valuation meeting be called. When a security is valued in accordance with the Fair Value Procedures, the Sponsor or its designees will determine the fair value after taking into consideration relevant information reasonably available to it.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

In accordance with the authoritative guidance on fair value measurements and disclosure under GAAP, the Funds disclose fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure the fair value. The objective of a fair value measurement is to determine the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). Accordingly, the fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).The three levels of the fair value hierarchy are described below:

Level 1	–	Unadjusted quoted prices in active markets for identical, unrestricted assets or liabilities that the Fund has the ability to access at the measurement date;

Level 2	–	Quoted prices which are not active, or inputs that are observable (either directly or indirectly) for substantially the full term of the asset or liability; and

Level 3	–	Prices, inputs or exotic modeling techniques which are both significant to the fair value measurement and unobservable (supported by little or no market activity).

In some instances, the inputs used to measure fair value might fall within different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls shall be determined based on the lowest input level that is significant to the fair value measurement in its entirety.

The following table summarizes the inputs used to value the Funds’ investments at September 30, 2021 and December 31, 2020 using the fair value hierarchy:

U.S. Equity Cumulative Dividends Fund—Series 2027

September 30, 2021 (Unaudited)

Investments in Securities	Level 1		Level 2		Level 3		Total

U.S. Treasury Obligations	$	-	$	30,449,028	$	-	$	30,449,028
Total Investments in Securities	$	-	$	30,449,028	$	-	$	30,449,028

Other Financial Instruments	Level 1			Level 2		Level 3		Total

Futures Contracts*
Unrealized Appreciation	$	829,842		$	-	$	-	$	829,842
Unrealized Depreciation		(36,422	)		-		-		(36,422	)
Total Other Financial Instruments	$	793,420		$	-	$	-	$	793,420

U.S. Equity Cumulative Dividends Fund—Series 2027

December 31, 2020 (Audited)

Investments in Securities	Level 1		Level 2		Level 3		Total

U.S. Treasury Obligations	$	-	$	18,835,724	$	-	$	18,835,724
Total Investments in Securities	$	-	$	18,835,724	$	-	$	18,835,724

Other Financial Instruments	Level 1			Level 2		Level 3		Total

Futures Contracts*
Unrealized Appreciation	$	-		$	-	$	-	$	-
Unrealized Depreciation		(2,915,316	)		-		-		(2,915,316	)
Total Other Financial Instruments	$	(2,915,316	)	$	-	$	-	$	(2,915,316	)

Futures contracts are valued at unrealized appreciation (depreciation) on the instrument.

Amounts designated as “-” are $0.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

U.S. Equity Ex-Dividend Fund—Series 2027

September 30, 2021 (Unaudited)

Investments in Securities	Level 1		Level 2		Level 3		Total

U.S. Treasury Obligations	$	-	$	34,899,810	$	-	$	34,899,810
Total Investments in Securities	$	-	$	34,899,810	$	-	$	34,899,810

Other Financial Instruments	Level 1			Level 2		Level 3		Total

Futures Contracts*
Unrealized Appreciation	$	63,328		$	-	$	-	$	63,328
Unrealized Depreciation		(2,065,813	)		-		-		(2,065,813	)
Total Other Financial Instruments	$	(2,002,485	)	$	-	$	-	$	(2,002,485	)

U.S. Equity Ex-Dividend Fund—Series 2027

December 31, 2020 (Audited)

Investments in Securities	Level 1		Level 2		Level 3		Total

U.S. Treasury Obligations	$	-	$	31,392,285	$	-	$	31,392,285
Total Investments in Securities	$	-	$	31,392,285	$	-	$	31,392,285

Other Financial Instruments	Level 1		Level 2		Level 3		Total

Futures Contracts*
Unrealized Appreciation	$	1,370,127	$	-	$	-	$	1,370,127
Unrealized Depreciation		-		-		-		-
Total Other Financial Instruments	$	1,370,127	$	-	$	-	$	1,370,127

Futures contracts are valued at unrealized appreciation (depreciation) on the instrument.

Amounts designated as “-” are $0.

The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.

Investment Transactions and Related Income

Investment transactions are recorded on trade date. Dividend income is recorded on the ex-dividend date. Discounts and premiums on securities purchased are amortized or accreted using the effective interest method. Realized gains and losses from securities transactions and unrealized appreciation and depreciation of securities are determined using the identified cost basis method for financial reporting.

Trading and Transaction Costs and Fees

Each Fund will pay (or will reimburse the Clearing FCM if previously paid) any other transaction costs and fees associated with trading of the Fund’s instruments (including floor brokerage, exchange, clearing, give-up, user and National Futures Association (“NFA”) fees) that are not related to the creation and redemption of Baskets. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is opened and the second half is recognized when the contract is closed).

Income Taxes

Each Fund is a series of a Delaware statutory trust and will be treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax; rather each beneficial owner of Shares will be required to take into account its allocable share of the Fund’s income, gain, loss deductions and other items for the Fund’s taxable year ending with or within the beneficial owner’s taxable year.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

The Funds file an income tax return in the U.S. federal jurisdiction and may file income tax returns in various U.S. states and foreign jurisdictions. Generally, the Funds are subject to income tax examinations by federal, state and local jurisdictions, where applicable.

The Funds are required to determine whether their tax positions are more likely than not to be sustained upon examination by the applicable taxing authority based on the technical merits of the position. Tax positions not deemed more-likely-than-not threshold would be recorded as a tax expense in the current period.

At September 30, 2021 and December 31, 2020, the Funds had no unrecognized tax benefits related to their tax positions. The Funds do not expect that their assessments related to unrecognized tax benefits will materially change over the next 12 months. However, the Funds’ conclusions may be subject to review and adjustment at a later date based on factors including, but not limited to, the nexus of income among various tax jurisdictions; compliance with U.S. federal, state and foreign tax laws; and changes in the administrative practices and precedents of the relevant taxing authorities.

The Funds’ policy is to classify interest and penalties associated with the failure to file U.S. federal and state income tax returns, as income tax expenses on their Statements of Operations. For the year ended December 31, 2020 and for the nine months ended September 30, 2021, the Funds did not incur any such interest or penalties.

Distribution Policy

The Dividend Fund expects to pay monthly cash distributions to its Shareholders throughout each calendar year. Such distributions shall, on an annual basis, before fees and expenses, equal all or a substantial portion of the Dividend Fund’s NAV attributable to the ordinary cash dividends accumulated by the Dividend Points Index for the year (as reflected in the current year’s S&P 500 Dividend Futures Contracts held by the Dividend Fund). Such distributions may consist of ordinary income, capital gains and/or return of capital whose character will be determined at fiscal year-end once final year-end figures have been calculated. The Dividend Fund’s capital gains, if any, for a calendar year may include any net unrealized appreciation in its futures contracts that expire in future calendar years.

The Ex-Dividend Fund does not anticipate making periodic distributions.

NOTE 3 – INVESTMENTS

The Dividend Fund seeks investment results that, before fees and expenses, correspond to the performance of the Solactive® U.S. Cumulative Dividends Index—Series 2027 (the “Solactive Dividend Index”) over each calendar year so as to provide Shareholders with returns designed to replicate the dividends on constituent companies of the S&P 500 Index, without exposure to the underlying securities. The Dividend Fund intends primarily to invest its assets in the component instruments of the Solactive Dividend Index, as well as in cash and/or cash equivalents. The component instruments of the Solactive Dividend Index consist of U.S. Treasury Securities (“Treasury Securities”) and long positions in annual futures contracts listed on the Chicago Mercantile Exchange (“CME”) that provide exposure to dividends paid on the S&P 500 constituent companies (“S&P 500 Dividend Futures Contracts”) pro rata for each year of the life of the Dividend Fund.

The Ex-Dividend Fund seeks investment results that, before fees and expenses, correspond to the performance of the Solactive® U.S. Equity Ex-Dividends Index—Series 2027 (the “Solactive Ex-Dividend Index”). The Ex-Dividend Fund seeks to track the Solactive Ex-Dividend Index so as to provide Shareholders with returns that are equivalent to the performance of 0.25 shares of SPDR S&P 500 exchange-traded fund (“SPY”) less the value of current and future expected ordinary cash dividends to be paid on the S&P 500 constituent companies over the term of the Ex-Dividend Fund. SPY is an exchange-traded fund that seeks to track the S&P 500. The Ex-Dividend Fund seeks to replicate the performance of SPY through owning long positions in quarterly S&P 500 Index futures contracts traded on the CME (“S&P 500 Index Futures Contracts”) rather than shares of SPY. Additionally, the Ex-Dividend Fund intends to track the performance of the Solactive Ex-Dividend Index by selling S&P 500 Dividend Futures Contracts. The Ex-Dividend Fund will also hold Treasury Securities, cash and/or cash equivalents.

Cash and Cash Equivalents

Cash and cash equivalents consist of highly liquid investments with original maturities of three months or less at the date of purchase. The Funds maintain deposits with financial institutions in amounts that may, at times, exceed the insured limits under applicable law.

Short-Term Investments

The Funds may purchase U.S. Treasury Bills, cash and or cash equivalents. Additionally, the Funds may enter into short-term loans and reverse repurchase agreements for liquidity purposes. There were no short-term loans or reverse repurchase agreements held in the Funds as of and during the period ended September 30, 2021 nor as of and during the period ended September 30, 2020.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

Accounting for Derivative Instruments

All open derivative positions at period end are reflected on each respective ETF’s Schedule of Investments. The ETFs utilized a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objective during the period. While the volume of open positions may vary on a daily basis as each ETF transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective ETF at the date of this report is generally representative of open positions throughout the reporting period. Following is a description of the derivative instruments used by the ETFs during the reporting period, including the primary underlying risk exposures related to each instrument type.

Futures Contracts

The ETFs enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying index, currency or commodity, as set forth above. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration of contract. The particular futures contracts utilized by the ETFs permit settlement only in cash. Upon entering into a futures contract, each ETF is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is affected.

The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the Statements of Financial Condition and Schedules of Investments, and is restricted as to its use. The ETFs that enter into futures contracts maintain collateral at the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of a futures transaction. Futures contracts involve, to varying degrees, elements of market risk (specifically commodity price risk or equity market volatility risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the market value of the underlying index or commodity and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the ETFs since futures contracts are exchange-traded and the exchange’s clearinghouse, as counterparty to all exchange-traded futures contracts, guarantees the futures contracts against default. Many futures exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund will be required to make daily cash payments of variation margin. The risk that the Fund will be unable to close out a futures position will be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.

The Funds held futures equity contracts as of and for the nine-month period ended September 30, 2021 and as of and for the year ended December 31, 2020. The value and detail of these contracts are disclosed on each fund’s respective Schedule of Investments. The corresponding gains and losses associated with these contracts are disclosed on each Fund’s respective Statement of Operations.

The average volume of futures contracts for the nine-month period ended September 30, 2021 are as follows:

U.S. Equity Cumulative Dividends Fund–Series 2027

Derivative		Notional Amount
Long futures contracts		$	28,365,952

U.S. Equity Ex-Dividend Fund–Series 2027

Derivative	Notional Amount
Long futures contracts	$	40,004,744
Short futures contracts	$	(4,613,340	)

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

The average volume of futures contracts for the nine-month period ended September 30, 2020 are as follows:

U.S. Equity Cumulative Dividends Fund–Series 2027

Derivative		Notional Amount
Long futures contracts		$	26,050,421

U.S. Equity Ex-Dividend Fund–Series 2027

Derivative	Notional Amount
Long futures contracts	$	30,155,027
Short futures contracts	$	(5,203,594	)

Offsetting Assets and Liabilities

The Futures Account Agreement includes provisions permitting the Clearing FCM to net and set off its obligations to the Fund against the obligations of the Fund to the Clearing FCM upon the termination of the agreement or occurrence of an Event of Default, as defined in the agreement. As described above, the Funds utilize derivative instruments to pursue their investment objective during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.

For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund’s derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of September 30, 2021 and December 31, 2020.

U.S. Equity Cumulative Dividends Fund—Series 2027

September 30, 2021 (Unaudited)

Offsetting of Derivative Assets

Gross
Amounts
Offset

Net
Amounts
Presented

Gross Amounts Not Offset in the

Gross

in the

Statement of Financial Condition

Amounts of
Recognized
Assets

Statement of
Financial
Condition

Financial
Instruments(a)

Cash
Collateral
Pledged(a)

Net
Amount

Derivative Assets

Futures Contracts

Total

Offsetting of Derivative Liabilities

				Gross Amounts Offset		Net Amounts Presented			Gross Amounts Not Offset in the
	Gross			in the		in the			Statement of Financial Condition
	Amounts of Recognized Liabilities			Statement of Financial Condition		Statement of Financial Condition			Financial Instruments(a)		Cash Collateral Pledged (a)		Net Amount
Derivative Liabilities
Futures Contracts	$	(92,000	)	$	-	$	(92,000	)	$	-	$	92,000	$	-
Total	$	(92,000	)	$	-	$	(92,000	)	$	-	$	92,000	$	-

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

December 31, 2020 (Audited)

Offsetting of Derivative Assets

			Gross Amounts Offset		Net Amounts Presented		Gross Amounts Not Offset in the
	Gross		in the		in the		Statement of Financial Condition
	Amounts of Recognized Assets		Statement of Financial Condition		Statement of Financial Condition		Financial Instruments(a)		Cash Collateral Pledged(a)		Net Amount
Derivative Assets
Futures Contracts	$	31,500	$	-	$	31,500	$	-	$	-	$	31,500
Total	$	31,500	$	-	$	31,500	$	-	$	-	$	31,500

Offsetting of Derivative Liabilities

				Gross Amounts Offset		Net Amounts Presented			Gross Amounts Not Offset in the
	Gross			in the		in the			Statement of Financial Condition
	Amounts of Recognized Liabilities			Statement of Financial Condition		Statement of Financial Condition			Financial Instruments(a)		Cash Collateral Pledged(a)		Net Amount
Derivative Liabilities
Futures Contracts	$	(26,250	)	$	-	$	(26,250	)	$	-	$	26,250	$	-
Total	$	(26,250	)	$	-	$	(26,250	)	$	-	$	26,250	$	-

(a)	These amounts are limited to the derivatives asset/liability balance and, accordingly, do not include excess collateral received/pledged.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

U.S. Equity Ex-Dividends Fund—Series 2027

September 30, 2021 (Unaudited)

Offsetting of Derivative Assets

			Gross Amounts Offset		Net Amounts Presented		Gross Amounts Not Offset in the
	Gross		in the		in the		Statement of Financial Condition
	Amounts of Recognized Assets		Statement of Financial Condition		Statement of Financial Condition		Financial Instruments(a)		Cash Collateral Pledged(a)		Net Amount
Derivative Assets
Futures Contracts	$	11,500	$	-	$	11,500	$	-	$	-	$	11,500
Total	$	11,500	$	-	$	11,500	$	-	$	-	$	11,500

Offsetting of Derivative Liabilities

				Gross Amounts Offset		Net Amounts Presented			Gross Amounts Not Offset in the
	Gross			in the		in the			Statement of Financial Condition
	Amounts of Recognized Liabilities			Statement of Financial Condition		Statement of Financial Condition			Financial Instruments(a)		Cash Collateral Pledged(a)		Net Amount
Derivative Liabilities
Futures Contracts	$	(520,000	)	$	-	$	(520,000	)	$	-	$	520,000	$	-
Total	$	(520,000	)	$	-	$	(520,000	)	$	-	$	520,000	$	-

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

December 31, 2020 (Audited)

Offsetting of Derivative Assets

			Gross Amounts Offset		Net Amounts Presented		Gross Amounts Not Offset in the
	Gross		in the		in the		Statement of Financial Condition
	Amounts of Recognized Assets		Statement of Financial Condition		Statement of Financial Condition		Financial Instruments(a)		Cash Collateral Pledged(a)		Net Amount
Derivative Assets
Futures Contracts	$	251,000	$	-	$	251,000	$	-	$	-	$	251,000
Total	$	251,000	$	-	$	251,000	$	-	$	-	$	251,000

Offsetting of Derivative Liabilities

				Gross Amounts Offset		Net Amounts Presented			Gross Amounts Not Offset in the
	Gross			in the		in the			Statement of Financial Condition
	Amounts of Recognized Liabilities			Statement of Financial Condition		Statement of Financial Condition			Financial Instruments(a)		Cash Collateral Pledged(a)		Net Amount
Derivative Liabilities
Futures Contracts	$	(6,000	)	$	-	$	(6,000	)	$	-	$	6,000	$	-
Total	$	(6,000	)	$	-	$	(6,000	)	$	-	$	6,000	$	-

(a)	These amounts are limited to the derivatives asset/liability balance and, accordingly, do not include excess collateral received/pledged.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

NOTE 4 – AGREEMENTS

Sponsor

Among other things, the prospectus dated July 9, 2021 (the “Prospectus”) provides for a unitary fee structure pursuant to which each Fund pays the Sponsor a management fee in consideration of the services provided by the Sponsor and other services provided to each Fund that the Sponsor pays directly (the “Management Fee”). The Sponsor pays for all of the routine operational, administrative, and other ordinary expenses of each Fund as determined by the Sponsor as set forth in the Prospectus any supplements thereto. The Funds will pay for certain other expenses and all of the Funds’ extraordinary fees and expenses, if any, as determined by the Sponsor, as set forth in the Prospectus any supplements thereto.

Administrator, Custodian, Fund Accountant and Transfer Agent

SEI Investments Global Fund Services, Inc. (the “Administrator”) serves as the Funds’ Administrator pursuant to an administration agreement. Brown Brothers Harriman & Co. (the “Custodian”) serves as the Funds’ custodian and transfer agent pursuant to a custodian and transfer agent agreement.

Clearing FCM

Morgan Stanley & Co. LLC (“MS&Co.” or the “Clearing FCM”) serves as the Fund’s Clearing FCM pursuant to the terms of a commodity futures customer agreement among the Sponsor, on behalf of the Funds, severally and not jointly, and the Clearing FCM (the “Futures Account Agreement”). As Clearing FCM, MS&Co. serves as the Funds’ clearing broker and as such arranges for the execution and clearing of the Funds’ futures transactions. As such, MS&Co. holds, on behalf of the Funds, positions in futures contracts and Treasury Securities, cash and cash equivalents as futures margin. Treasury Securities, cash and cash equivalents not held as futures margin will be held by the Custodian. The Funds may engage additional and/or other futures commission merchants in the future.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

Distribution Agreement

SEI Investments Distribution Co., a wholly-owned subsidiary of SEI Investments and an affiliate of the Administrator, serves as the Funds’ distributor of Baskets pursuant to a distribution agreement. The Distributor does not maintain any secondary market in the Shares.

Management Fee/Advisory Fee

The Management Fee is paid to the Sponsor in consideration of its services as sponsor, commodity pool operator, commodity trading advisor, and for managing the business and affairs of the Funds. The Sponsor supervises and directs the investment of the assets of the Funds in accordance with the Funds’ investment objectives and investment strategies outlined in the Funds’ Prospectus.

As set forth in the Prospectus, the Dividend Fund pays the Sponsor a Management Fee equal to 0.87% per year of the Dividend Fund’s average daily net assets, calculated and payable monthly in arrears, or pro rata for any partial month. The Ex-Dividend Fund pays the Sponsor a Management Fee equal to 0.58% per year of the Ex-Dividend Fund’s average daily net assets, calculated and payable monthly in arrears, or pro rata for any partial month.

NOTE 5 – CREATION AND REDEMPTION OF CREATION UNITS

The Funds issue and redeem Shares on a continuous basis at NAV in one or more large blocks of Shares called Baskets as set forth in the Funds’ Prospectus and any prospectus supplements thereto. Each Fund intends to create and redeem Baskets primarily through exchange for related position (“EFRP”) transactions. In certain instances, the Funds may effect creations and redemptions partly or wholly for cash, rather than through an EFRP transaction.

The manner by which redemptions are made is dictated by the terms of the respective authorized participant agreement between an Authorized Participant and the Trust (“Authorized Participant Agreement”). Except when aggregated in Baskets, Shares are not redeemable securities of a Fund. Shares of the Funds may be purchased or redeemed only by Authorized Participants. An Authorized Participant is an institution that (i) is a broker-dealer; (ii) is a registered futures commission merchant and/or clears through a registered futures commission merchant; (iii) is a Depository Trust Company Participant and a member of the National Securities Clearing Corporation; (iv) has entered into an Authorized Participant agreement with the Trust; and (v) is in a position to transfer the required Deposit Instruments and/or the cash to buy and sell whole Baskets. Investors will purchase Shares in the secondary market, generally with the assistance of a broker or investment advisor and will be subject to customary brokerage commissions, mark ups and mark downs and fees.

Authorized Participants will pay a transaction fee per Basket created or redeemed. The Sponsor may choose to pay transaction fees on behalf of Authorized Participants and has done so to date on Baskets that have been created. There is no guarantee that Sponsor will continue to do so. In addition, to the extent that cash is delivered or received in lieu of any of the Deposit Instruments upon the creation or redemption of Shares by an Authorized Participant, such Authorized Participants will pay an additional variable charge up to 2% of the cash that is delivered or received in lieu of any of the Deposit Instruments to a Fund to pay for any additional transaction costs and fees and price changes associated with the purchase or disposition of any of the Deposit Instruments.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

NOTE 6 – FINANCIAL HIGHLIGHTS

Selected data for a Share outstanding throughout the periods ended September 30, 2021:

Financial Highlights

Three Months Ended September 30, 2021 (Unaudited)

	NAV Beginning of Period		Net Investment Income/Loss*			Net Realized and Unrealized Gain/Loss		Total from Operations		Distributions from Net Investment Income			Total Distributions			NAV End of Period		Total Return⁽¹⁾			Market Price		Net Assets End of Period (000)		Ratio of Expenses to Average Net Assets ⁽³⁾			Ratio of Expenses to Average Net Assets (Excluding Waivers) ⁽³⁾			Ratio of Net Investment Income/Loss to Average Net Assets ⁽³⁾			Portfolio Turnover ⁽²⁾
U.S. Equity Cumulative Dividends Fund—Series 2027
2021	$	9.92	$	(0.01	)	$	0.21	$	0.20	$	(0.35	)	$	(0.35	)	$	9.77		1.98	%	$	10.57	$	31,256		0.87	%		0.87	%		-0.42	%		2	%

U.S. Equity Ex-Dividend Fund—Series 2027
2021	$	96.25	$	(0.15	)	$	0.24	$	0.09	$	-		$	-		$	96.34		0.09	%	$	97.01	$	38,538		0.58	%		0.58	%		-0.60	%		0	%

*	Per share data calculated using average shares method.

⁽¹⁾	Total return is for the period indicated and has not been annualized.

⁽²⁾	Portfolio turnover rate is for the period indicated and has not been annualized.

⁽³⁾	Annualized

Amounts designated as “-” are $0.

Financial Highlights

Nine Months Ended September 30, 2021 (Unaudited)

	NAV Beginning of Period		Net Investment Income/Loss*			Net Realized and Unrealized Gain/Loss		Total from Operations		Distributions from Net Investment Income			Total Distributions			NAV End of Period		Total Return⁽¹⁾			Market Price		Net Assets End of Period (000)		Ratio of Expenses to Average Net Assets ⁽³⁾			Ratio of Expenses to Average Net Assets (Excluding Waivers) ⁽³⁾			Ratio of Net Investment Income/Loss to Average Net Assets ⁽³⁾			Portfolio Turnover ⁽²⁾
U.S. Equity Cumulative Dividends Fund—Series 2027
2021	$	9.39	$	(0.03	)	$	1.42	$	1.39	$	(1.01	)	$	(1.01	)	$	9.77		15.55	%	$	10.57	$	31,256		0.87	%		0.87	%		-0.44	%		10	%

U.S. Equity Ex-Dividend Fund—Series 2027
2021	$	83.94	$	(0.41	)	$	12.81	$	12.40	$	-		$	-		$	96.34		14.77	%	$	97.01	$	38,538		0.58	%		0.58	%		-0.59	%		0	%

*	Per share data calculated using average shares method.

⁽¹⁾	Total return is for the period indicated and has not been annualized.

⁽²⁾	Portfolio turnover rate is for the period indicated and has not been annualized.

⁽³⁾	Annualized

Amounts designated as “-” are $0.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

Financial Highlights

Three Months Ended September 30, 2020 (Unaudited)

	NAV Beginning of Period		Net Investment Income/Loss*			Net Realized and Unrealized Gain/Loss		Total from Operations		Distributions from Net Investment Income			Total Distributions			NAV End of Period		Total Return(1)			Market Price		Net Assets End of Period (000)		Ratio of Expenses to Average Net Assets (3)			Ratio of Expenses to Average Net Assets (Excluding Waivers) (3)			Ratio of Net Investment Income/Loss to Average Net Assets (3)			Portfolio Turnover (2)
U.S. Equity Cumulative Dividends Fund—Series 2027 *
2020	$	9.32	$	(0.01	)	$	0.22	$	0.21	$	(0.31	)	$	(0.31	)	$	9.22		2.28	%	$	9.49	$	18,908		0.87	%		0.87	%		-0.46	%		5	%

U.S. Equity Ex-Dividend Fund—Series 2027 *
2020	$	67.05	$	(0.10	)	$	6.59	$	6.49	$	-		$	-		$	73.54		9.68	%	$	73.36	$	29,415		0.58	%		0.58	%		-0.53	%		0	%

*	Per share data calculated using average shares method.

⁽¹⁾	Total return is for the period indicated and has not been annualized.

⁽²⁾	Portfolio turnover rate is for the period indicated and has not been annualized.

⁽³⁾	Annualized

Amounts designated as “-” are $0.

Nine Months Ended September 30, 2020 (Unaudited)

	NAV Beginning of Period		Net Investment Income/Loss*			Net Realized and Unrealized Gain/Loss			Total from Operations			Distributions from Net Investment Income			Total Distributions			NAV End of Period		Total Return(1)			Market Price		Net Assets End of Period (000)		Ratio of Expenses to Average Net Assets (3)			Ratio of Expenses to Average Net Assets (Excluding Waivers) (3)			Ratio of Net Investment Income/Loss to Average Net Assets (3)			Portfolio Turnover (2)
U.S. Equity Cumulative Dividends Fund—Series 2027 *
2020	$	11.85	$	0.01		$	(1.63	)	$	(1.62	)	$	(1.01	)	$	(1.01	)	$	9.22		-13.61	%	$	9.49	$	18,908		0.87	%		0.87	%		0.13	%		91	%

U.S. Equity Ex-Dividend Fund—Series 2027 *
2020	$	67.35	$	(0.02	)	$	6.21		$	6.19		$	-		$	-		$	73.54		9.19	%	$	73.36	$	29,415		0.58	%		0.58	%		-0.04	%		0	%

*	Per share data calculated using average shares method.

⁽¹⁾	Total return is for the period indicated and has not been annualized.

⁽²⁾	Portfolio turnover rate is for the period indicated and has not been annualized.

⁽³⁾	Annualized

Amounts designated as “-” are $0.

NOTE 7 – RISK

Principal Risks

A shareholder of the Funds is subject to the risk that his or her investment could lose money. The Funds are subject to the principal risks noted below, any of which may adversely affect a Fund’s NAV, trading price, yield, total return and ability to meet its investment objective. A more complete description of principal risks is included in the Prospectus under the heading “Principal Risks.” This could result in the Funds’ underperformance compared to other funds with similar investment objectives.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

Market Trading Risks

Individual Shares may be purchased and sold only on a national securities exchange, an alternative trading system, or in the over-the-counter market and may not be directly purchased or redeemed from the Funds. There can be no guarantee that an active trading market for Shares will develop or be maintained, or that the listing of the Shares will continue unchanged. Buying and selling Shares may require a shareholder to pay brokerage commissions and expose a shareholder to other trading costs. Due to brokerage commissions and other transaction costs that may apply, frequent trading may detract from realized investment returns. Trading prices of Shares may be above, at or below the Funds’ NAV, will fluctuate in relation to NAV based on supply and demand in the market for Shares and other factors, and may vary significantly from NAV during periods of market volatility. The return on an investor’s investment will be reduced when the investor sells Shares at a discount or buys Shares at a premium to NAV.

Contingent Pricing Risks

Creation and redemption prices of Baskets are directly linked to the Funds’ next-computed NAV, which is normally determined at the end of each business day. Buyers and sellers of Shares will not know the value of their purchases and sales until the Funds’ NAV is determined at the end of the trading day. Like mutual funds, the Funds do not offer opportunities to purchase or redeem Baskets intraday at currently determined (as opposed to end-of-day) prices. Creation and redemption prices of Baskets are contingent upon the determination of NAV and may vary significantly from anticipated levels (including estimates based on intraday indicative values disseminated by the Funds) during periods of market volatility. Although limit orders can be used to restrict differences between prices of the Shares in the secondary market and NAV (i.e., premiums and discounts to NAV), they cannot be used to specify trade execution prices. However, unlike shares of mutual funds, Shares will trade on NYSE Arca, Inc. during the day at market-determined prices. The Funds will disseminate an indicative NAV every 15 seconds during the trading day.

Cash Transactions Risk

Each Fund intends to create and redeem Baskets primarily through EFRP transactions. In certain instances, the Funds may effect creations and redemptions partly or wholly for cash, rather than through an EFRP transaction. Because the Funds may effect redemptions for cash, rather than through an EFRP transaction, they may be required to sell Deposit Instruments in order to obtain the cash needed to distribute redemption proceeds, and they may subsequently recognize gains on such sales. As a result, an investment in Shares redeemed partially or wholly for cash may be less tax-efficient than if the Shares were redeemed through an EFRP transaction which generally will not trigger any tax consequences to Shareholders. Moreover, cash transactions may have to be carried out over several days if the market for any of the Deposit Instruments is relatively illiquid and may involve considerable brokerage fees and taxes. These brokerage fees and taxes, which generally are expected to be higher than if the Basket was created or redeemed through an EFRP transaction, may be passed on to purchasers and redeemers of Baskets in the form of creation and redemption transaction fees. In addition, these factors may result in wider spreads between the bid and the offered prices of the Shares.

Authorized Participant Concentration Risk

Only an Authorized Participant may engage in creation or redemption transactions directly with the Funds. The Funds may have relationships with a limited number of institutions that act as Authorized Participants. To the extent these institutions exit the business or are unable or unwilling to proceed with creation and/or redemption orders with respect to the Funds and no other Authorized Participant is able to step forward to create or redeem Baskets, Shares of the Funds may trade at a discount to NAV and possibly face trading halts and/or delisting.

Substantial Interests of each Fund are Held by a Small Number of Investors and Authorized Participants.

A substantial portion of the Shares of each Fund are held by a small number of investors, Beneficial Owners and Authorized Participants. Additionally, at any future time, and from time to time, a substantial portion of the Shares of either Fund may be held by one or a small number of investors, Beneficial Owners and/or Authorized Participants. In the event of substantial redemptions of Shares by one or more of these persons the Shares could be impacted adversely.

METAURUS EQUITY COMPONENT TRUST

NOTES TO FINANCIAL STATEMENTS

September 30, 2021

(unaudited)

Guarantees and Indemnifications

In the normal course of business, the Funds enter into contracts with third-party service providers that contain a variety of representations and warranties and that provide general indemnifications. Additionally, under the Funds’ organizational documents, the Sponsor, Wilmington Trust, N.A., a national banking association and the trustee of the Trust, and their officers and affiliates are indemnified against certain liabilities arising out of the performance of their duties to the Funds. The Funds’ maximum exposure under these arrangements is unknown, as it involves possible future claims that may or may not be made against the Funds. Based on experience, the Sponsor is of the view that the risk of loss to the Funds in connection with the Funds’ indemnification obligations is remote; however, there can be no assurance that such obligations will not result in material liabilities that adversely affect the Funds.

Natural Disaster/Epidemic Risk.

Natural or environmental disasters, such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease, including pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and markets and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster and health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays, shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding results on the operating performance of the Funds. A climate of uncertainty and panic, including the contagion of infectious viruses or diseases, may adversely affect global, regional, and local economies. These circumstances may adversely impact the Funds’ performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual companies (including, but not limited to, the Funds’ Sponsor and third-party service providers), sectors, industries, markets, securities and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Funds’ Underlying Indexes. These factors can cause substantial market volatility, exchange trading suspensions and closures, changes in the availability of and the margin requirements for certain instruments, and can impact the ability of the Funds to complete redemptions and otherwise affect the Funds’ performance and the Funds’ trading in the secondary market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long such events will last and whether they will continue or recur cannot be predicted. Impacts from these could have a significant impact on the Funds’ performance, resulting in losses to your investment.

Risk that Current Assumptions and Expectations Could Become Outdated as a Result of Global Economic Shock.

The onset of the novel coronavirus (COVID-19) has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow and contain the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies as economic activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at least equal to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market in the fastest such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US, oil experienced shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as of the date hereof may result in significant losses to your investment.

NOTE 8 – SUBSEQUENT EVENTS

On November 12, 2021, the Sponsor notified the NYSE Arca stock exchange that it has determined to close the Ex-Dividend Fund and delist and liquidate the Ex-Dividend Fund’s shares from trading on the NYSE Arca. The Ex-Dividend Fund will no longer accept creation and redemption orders after December 9, 2021. Trading in the Ex-Dividend Fund shares will be suspended following the market close on December 10, 2021. Proceeds of the liquidation are currently scheduled to be sent to shareholders on or about December 17, 2021.

In preparing these financial statements, management has evaluated events and transactions for potential recognition or disclosure through the date the financial statements were issued. Management has determined that there are no material events, except as set forth above that would require disclosure in the Funds’ financial statements through this date.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion should be read in conjunction with the financial statements and the notes thereto of Metaurus Equity Component Trust (the “Trust”) included elsewhere in this quarterly report on Form 10-Q, as well as the financial statements included in the Trust’s Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the SEC on March 31, 2021.

Forward-Looking Information

This quarterly report on Form 10-Q, including this “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements regarding the plans and objectives of management for future operations. This information may involve known and unknown risks, uncertainties and other factors that may cause the Trust’s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by any forward-looking statements. Forward-looking statements, which involve assumptions and describe the Trust’s future plans, strategies and expectations, are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend” or “project,” the negative of these words, other variations on these words or comparable terminology. These forward-looking statements are based on assumptions that may be incorrect, and the Trust cannot assure investors that the projections included in these forward-looking statements will come to pass. the Trust’s actual results could differ materially from those expressed or implied by the forward-looking statements as a result of various factors.

The Trust has based the forward-looking statements included in this quarterly report on Form 10-Q on information available to it on the date of this quarterly report on Form 10-Q, and the Trust assumes no obligation to update any such forward-looking statements. Although the Trust undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, investors are advised to consult any additional disclosures that the Trust may make directly to them or through reports that the Trust in the future files with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

Introduction

The Metaurus Equity Component Trust (the “Trust”) is a statutory trust formed under the laws of the State of Delaware in September 2016. The Trust is neither managed like a corporation nor registered as an investment company under the Investment Company Act of 1940 and is not required to register under such act.

The U.S. Equity Cumulative Dividends Fund—Series 2027 (the “Dividend Fund”) and the U.S. Equity Ex-Dividend Fund—Series 2027 (the “Ex-Dividend Fund”, and together with the Dividend Fund, the “Funds” and each, a “Fund”) are separate series of the Trust. Each Fund is a commodity pool that will issue shares to shareholders (“Shareholders”) representing fractional undivided beneficial interests in, and ownership of, the net assets of the Fund (“Shares”). The Funds are each passive, unleveraged investment pools.

Shares in each Fund are being separately offered. The Funds are term funds that will terminate on or prior to December 31, 2027. Each of the Funds began issuing shares on February 5, 2018, and their units of beneficial interest (“Shares”) represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the New York Stock Exchange Archipelago (a/k/a NYSE Arca). The Trust qualifies as an “emerging growth company” subject to reduced public company reporting requirements under U.S. federal securities laws.

Metaurus Advisors LLC (“Metaurus”) is the sponsor, commodity pool operator and commodity trading advisor of each Fund. Metaurus, a limited liability company formed in the State of Delaware on September 15, 2016, serves as the Trust’s Sponsor, commodity pool operator and commodity trading advisor. The Sponsor is exempt from registration as a commodity trading advisor with the CFTC under CFTC Rule 4.14(a)(4), as the Sponsor is registered as a commodity pool operator, and the Sponsor’s commodity trading advice is directed solely to, and for the sole use of, the Funds, pools for which it is so registered. The address of Metaurus is 22 Hudson Place, Suite 3, Hoboken, NJ 07030. The main business telephone number of Metaurus is (201) 683-7979. The Trust had no investment operations prior to February 5, 2018, other than matters relating to its organization, the registration of each series under the Securities Act of 1933, as amended, and the contribution of $1,000 in each Fund by the Sponsor.

The Sponsor is responsible for making operational decisions necessary to maintain the proper number of investment positions to meet the investment objectives of the Funds, monitor the performance results of the Funds’ portfolios and reallocate assets within the portfolios with a view to causing the performance of each Fund’s portfolio to track that of its Underlying Index over each calendar year. Each Fund is designed to terminate operations in December 2027.

Each of the Funds generally invests 100% of its assets in U.S Treasury Securities, cash and cash equivalent securities and seeks to gain exposure to certain financial futures whose value is derived from the underlying assets, as a substitute for investing directly in U.S equity securities directly, in order to gain or lose exposure to certain component of their return.

More specifically, the Dividend Fund is a passive, unleveraged fund that seeks to track the Solactive U.S. Cumulative Dividends Index - Series 2027 (the “Dividends Index”). The Dividends Index (and the Dividend Fund) seeks to represent the discounted present value of all dividend futures contracts out to and including December 2027. Each annual dividend futures contract represents the total value of all dividends paid on the S&P 500 Index constituent stocks during the contract year (as measured from mid-December to mid-December). The Dividend Fund holds a portfolio of sequentially maturing U.S. Treasury Notes and cash. In order to gain exposure to the annual dividends paid on the S&P 500 Index in each year, the Dividend Fund holds long positions in the series of annual dividend futures contracts that are linked to the amounts of dividends paid on the S&P 500 Index constituent stock in each year during the term of the Dividend Fund. Unlike most futures contracts, dividend futures contracts do not need to be “rolled” periodically but may be held to their annual expiry.

The Ex-Dividend Fund is a passive, unleveraged fund that seeks to track the Solactive U.S. Ex-Dividends Index - Series 2027 (the “Ex-Dividends Index”). The Ex-Dividends Index (and the Ex-Dividend Fund) seeks to gain exposure to U.S. equities at a discounted price by holding 100% of its assets in short-term U.S. Treasury securities and cash and gaining exposure to the U.S. equity market by holding long positions in S&P 500 Index futures and short positions in S&P 500 dividend futures contracts. The short positions in the dividend futures contracts allow the fund to access index exposure at a discount to purchasing shares of the index itself.

Each Fund continuously offers and redeems its Shares in blocks of Shares as set forth in the Prospectus and any prospectus supplements thereto (each such block a “Creation Unit”). Only Authorized Participants may purchase and redeem Shares from a Fund and then only in Creation Units. An Authorized Participant is an entity that has entered into an Authorized Participant Agreement with one or more of the Funds. Shares of the Funds are offered to Authorized Participants in Creation Units at each Fund’s respective NAV. Authorized Participants may then offer to the public, from time to time, Shares from any Creation Unit they create at a per-Share market price that varies depending on, among other factors, the trading price of the Shares of each Fund on the NYSE Arca, the NAV and the supply of and demand for the Shares at the time of the offer. Shares from the same Creation Unit may be offered at different times and may have different offering prices based upon the above factors. The form of Authorized Participant Agreement and related Authorized Participant Handbook set forth the terms and conditions under which an Authorized Participant may purchase or redeem a Creation Unit. Authorized Participants do not receive from any Fund, the Sponsor, or any of their affiliates, any underwriting fees or compensation in connection with their sale of Shares to the public.

Liquidity and Capital Resources

In order to maintain margin on futures positions held by the Funds, a portion of the NAV of each Fund is held in cash and/or U.S. Treasury securities at Morgan Stanley, the Funds’ Futures Commission Merchant, and, in the case of the Dividend Fund, to fund its monthly distributions. The Funds also maintain cash positions to fund certain fees and expenses of the Funds. The percentage that U.S. Treasury bills and other short-term cash positions held by the Funds can be expected to vary from period to period as the market values of the underlying futures contracts change.

The Sponsor is not aware of any other demands, commitments, events or uncertainties that are reasonably likely to result in material changes to the liquidity needs of either Fund. The Sponsor pays for all routine operational, administrative, and other ordinary expenses of each Fund as determined by the Sponsor as set forth in the Prospectus. The Funds pay for certain other expenses and all of the Funds’ extraordinary fees and expenses, if any, as determined by the Sponsor, as set forth in the Prospectus.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

See Note 7 – RISK, above.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

The duly authorized officers of the Sponsor, performing functions equivalent to those a principal executive officer and principal financial officer of the Trust would perform if the Trust had any officers, have evaluated the effectiveness of the Trust’s disclosure controls and procedures, and have concluded that the disclosure controls and procedures of the Trust were effective as of the end of the period covered by this report. Such disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed in the reports that the Trust files or submits under the Securities Exchange Act of 1934, as amended, are recorded, processed, summarized and reported, within the time period specified in the applicable rules and forms, and that such information is accumulated and communicated to the duly authorized officers of the Sponsor performing functions equivalent to those a principal executive officer and principal financial officer of the Trust would perform if the Trust had any officers, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There has been no change in the internal control over financial reporting that occurred during the fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Trust’s internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

From time to time, the Funds may receive subpoenas or other requests for information from various U.S. federal, state governmental and domestic and international regulatory authorities in connection with certain industry-wide or other investigations or proceedings. It is the Funds’ general policy to cooperate fully with such inquiries. The Funds may also be named as defendants in legal actions, including arbitrations and other litigation arising in connection with their activities, any of which potentially could harm the investment returns of the Fund or result in it being liable for any resulting damages.

The Sponsor, after consultation with legal counsel, currently does not anticipate that the aggregate liability arising out of regulatory matters or lawsuits, if any, will have a material effect on either Fund’s results of operations, financial position, or cash flows. However, there is no assurance as to whether any such pending or threatened matters, if any, will have a material effect on a Fund’s results of operations, financial position or cash flows in any future reporting period. Due to uncertainties surrounding the outcome of these matters, if any, the Funds cannot reasonably estimate the possible loss or range of loss that may arise from these matters, if any.

Item 1A. Risk Factors.

In addition to the risk factors set forth in Note 7, above. Shareholders should carefully consider the factors discussed beginning Page 11 “Risk Factors” in the Prospectus which could materially affect our business, financial condition or future results. The risks described in the Prospectus are not the only risks facing the Trust. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

b)	Not applicable.

c)	For the nine months ended September 30, 2021: 0 Baskets were redeemed.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

Exhibit Number		Description

31.1*		Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*		Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Metaurus Advisors LLC
	Sponsor of the Metaurus Equity Component Trust
	(Registrant)

Date: November 15, 2021	By:	/s/ Jamie Greenwald
		Jamie Greenwald
		Co-Chief Executive Officer (Principal Executive Officer)

Date: November 15, 2021	By:	/s/ Donald M. Callahan
		Donald M. Callahan
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

*	The Registrant is a trust and the persons are signing in their capacities as officers of Metaurus Advisors LLC, the Sponsor of the Registrant.

10237069 31255639 0.328 0.0225 0.0225 0.0225 0.0200 0.0200 0.953 10797858 19713753 0.5480 0.0225 0.0225 0.0225 0.0225 0.0200 0.0200 0.9550 0.9550 Security, or a portion of, has been pledged as collateral for the trading of futures contracts. The market value of the securities pledged as collateral for the period ended September 30, 2021 was $10,237,069 or 32.8% of net assets. Security, or a portion of, has been pledged as collateral for the trading of futures contracts. The market value of the securities pledged as collateral for the period ended December 31, 2020 was $10,797,858 or 54.8% of net assets. 22397760 34899810 38537510 0.00033 0.581 0.906 0.906 22393280 31389680 33575230 0.667 0.935 0.935 Security, or a portion of, has been pledged as collateral for the trading of futures contracts. The market value of the securities pledged as collateral for the period ended September 30, 2021 was $22,397,760 or 58.1% of net assets. Zero coupon security. The rate reported on the Schedule of Investments is the effective yield at time of purchase. Security, or a portion of, has been pledged as collateral for the trading of futures contracts. The market value of the securities pledged as collateral for the period ended December 31, 2020 was $22,393,280 or 66.7% of net assets. These amounts are limited to the derivatives asset/liability balance and, accordingly, do not include excess collateral received/pledged. Per share data calculated using average shares method. Annualized Total return is for the period indicated and has not been annualized. Portfolio turnover rate is for the period indicated and has not been annualized. false --12-31 Q3 0001688487 0001688487 2021-01-01 2021-09-30 0001688487 2021-10-22 0001688487 xdiv:EquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:EquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:EquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:EquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:UsEquityExDividendFundMember 2021-09-30 0001688487 xdiv:UsEquityExDividendFundMember 2020-12-31 0001688487 xdiv:UsEquityExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:UsEquityExDividendFundMember 2020-01-01 2020-12-31 0001688487 xdiv:UsEquityCumulativeDividendsFundMember 2021-07-01 2021-09-30 0001688487 xdiv:UsEquityCumulativeDividendsFundMember 2020-07-01 2020-09-30 0001688487 xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-09-30 0001688487 xdiv:EquityExDividendFundMember 2021-07-01 2021-09-30 0001688487 xdiv:EquityExDividendFundMember 2020-07-01 2020-09-30 0001688487 xdiv:EquityExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:EquityExDividendFundMember 2020-01-01 2020-09-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-01-01 2021-09-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-01-01 2020-09-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2019-12-31 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2021-01-01 2021-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2020-01-01 2020-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2019-12-31 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2020-09-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-01-01 2021-09-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-01-01 2020-09-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2019-12-31 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2021-01-01 2021-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2020-01-01 2020-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2019-12-31 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2020-09-30 0001688487 2021-09-30 0001688487 2020-12-31 0001688487 xdiv:InvestmentMember 2021-09-30 0001688487 xdiv:InvestmentMember 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesOneMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesOneMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesTwoMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesTwoMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesThreeMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesThreeMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesFourMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesFourMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesFiveMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesFiveMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesSixMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesSixMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesSevenMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesSevenMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 us-gaap:USTreasurySecuritiesMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 us-gaap:InvestmentsMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:UsTreasuryNotesSecuritiesOneMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesOneMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesTwoMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesTwoMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesThreeMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesThreeMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesFourMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesFourMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesFiveMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesFiveMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesSixMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesSixMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesSevenMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:UsTreasuryNotesSecuritiesSevenMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 us-gaap:USTreasurySecuritiesMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 us-gaap:InvestmentsMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:TypeOnContractsOneMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:TypeOnContractsOneMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractTwoMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:TypeOnContractTwoMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractThreeMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:TypeOnContractThreeMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractFourMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:TypeOnContractFourMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractFiveMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:TypeOnContractFiveMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractSixMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:TypeOnContractSixMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractSevenMember xdiv:UsEquityCumulativeDividendsFundMember 2021-09-30 0001688487 xdiv:TypeOnContractSevenMember xdiv:UsEquityCumulativeDividendsFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractsOneMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:TypeOnContractsOneMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractTwoMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:TypeOnContractTwoMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractThreeMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:TypeOnContractThreeMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractFourMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:TypeOnContractFourMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractFiveMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:TypeOnContractFiveMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractSixMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:TypeOnContractSixMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractSevenMember xdiv:UsEquityCumulativeDividendsFundMember 2020-12-31 0001688487 xdiv:TypeOnContractSevenMember xdiv:UsEquityCumulativeDividendsFundMember 2020-01-01 2020-12-31 0001688487 xdiv:USEquityExDividendFundSeries2027Member xdiv:UsTreasuryNotesSecuritiesEightMember 2021-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member xdiv:UsTreasuryNotesSecuritiesEightMember 2021-01-01 2021-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2021-01-01 2021-09-30 0001688487 us-gaap:USTreasurySecuritiesMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:InvestmentsMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member xdiv:UsTreasuryNotesSecuritiesNineMember 2020-12-31 0001688487 xdiv:USEquityExDividendFundSeries2027Member xdiv:UsTreasuryNotesSecuritiesNineMember 2020-01-01 2020-12-31 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2020-01-01 2020-12-31 0001688487 us-gaap:USTreasurySecuritiesMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:InvestmentsMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 xdiv:TypeOnContractsOneMember xdiv:EquityExDividendFundMember 2021-09-30 0001688487 xdiv:TypeOnContractsOneMember xdiv:EquityExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractTwoMember xdiv:EquityExDividendFundMember 2021-09-30 0001688487 xdiv:TypeOnContractTwoMember xdiv:EquityExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractThreeMember xdiv:EquityExDividendFundMember 2021-09-30 0001688487 xdiv:TypeOnContractThreeMember xdiv:EquityExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractFourMember xdiv:EquityExDividendFundMember 2021-09-30 0001688487 xdiv:TypeOnContractFourMember xdiv:EquityExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractFiveMember xdiv:EquityExDividendFundMember 2021-09-30 0001688487 xdiv:TypeOnContractFiveMember xdiv:EquityExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractSixMember xdiv:EquityExDividendFundMember 2021-09-30 0001688487 xdiv:TypeOnContractSixMember xdiv:EquityExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractSevenMember xdiv:EquityExDividendFundMember 2021-09-30 0001688487 xdiv:TypeOnContractSevenMember xdiv:EquityExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:TypeOnContractEightMember xdiv:EquityExDividendFundMember 2021-09-30 0001688487 xdiv:TypeOnContractEightMember xdiv:EquityExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:EquityExDividendFundMember 2021-09-30 0001688487 xdiv:TypeOnContractsOneMember xdiv:EquityExDividendFundMember 2020-12-31 0001688487 xdiv:TypeOnContractsOneMember xdiv:EquityExDividendFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractTwoMember xdiv:EquityExDividendFundMember 2020-12-31 0001688487 xdiv:TypeOnContractTwoMember xdiv:EquityExDividendFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractThreeMember xdiv:EquityExDividendFundMember 2020-12-31 0001688487 xdiv:TypeOnContractThreeMember xdiv:EquityExDividendFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractFourMember xdiv:EquityExDividendFundMember 2020-12-31 0001688487 xdiv:TypeOnContractFourMember xdiv:EquityExDividendFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractFiveMember xdiv:EquityExDividendFundMember 2020-12-31 0001688487 xdiv:TypeOnContractFiveMember xdiv:EquityExDividendFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractSixMember xdiv:EquityExDividendFundMember 2020-12-31 0001688487 xdiv:TypeOnContractSixMember xdiv:EquityExDividendFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractSevenMember xdiv:EquityExDividendFundMember 2020-12-31 0001688487 xdiv:TypeOnContractSevenMember xdiv:EquityExDividendFundMember 2020-01-01 2020-12-31 0001688487 xdiv:TypeOnContractEightMember xdiv:EquityExDividendFundMember 2020-12-31 0001688487 xdiv:TypeOnContractEightMember xdiv:EquityExDividendFundMember 2020-01-01 2020-12-31 0001688487 xdiv:EquityExDividendFundMember 2020-12-31 0001688487 2017-12-10 2017-12-22 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UsTreasuryObligationsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UsTreasuryObligationsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UsTreasuryObligationsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 xdiv:UsTreasuryObligationsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UnrealizedAppreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UnrealizedAppreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UnrealizedAppreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 xdiv:UnrealizedAppreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UnrealizedDepreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UnrealizedDepreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UnrealizedDepreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 xdiv:UnrealizedDepreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UsTreasuryObligationsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UsTreasuryObligationsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UsTreasuryObligationsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 xdiv:UsTreasuryObligationsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UnrealizedAppreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UnrealizedAppreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UnrealizedAppreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 xdiv:UnrealizedAppreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UnrealizedDepreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UnrealizedDepreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UnrealizedDepreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 xdiv:UnrealizedDepreciationMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UsTreasuryObligationsMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UsTreasuryObligationsMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UsTreasuryObligationsMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 xdiv:UsTreasuryObligationsMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UnrealizedAppreciationMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UnrealizedAppreciationMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UnrealizedAppreciationMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 xdiv:UnrealizedAppreciationMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UnrealizedDepreciationMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UnrealizedDepreciationMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UnrealizedDepreciationMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 xdiv:UnrealizedDepreciationMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UsTreasuryObligationsMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UsTreasuryObligationsMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UsTreasuryObligationsMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 xdiv:UsTreasuryObligationsMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UnrealizedAppreciationMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UnrealizedAppreciationMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UnrealizedAppreciationMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 xdiv:UnrealizedAppreciationMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel1Member xdiv:UnrealizedDepreciationMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel2Member xdiv:UnrealizedDepreciationMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 us-gaap:FairValueInputsLevel3Member xdiv:UnrealizedDepreciationMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 xdiv:UnrealizedDepreciationMember xdiv:USEquityExDividendFundSeries2027Member 2020-12-31 0001688487 xdiv:USCumulativeDividendsIndexSeries2027Member 2021-01-01 2021-09-30 0001688487 xdiv:USEquityExDividendsIndexSeries2027Member 2021-01-01 2021-09-30 0001688487 xdiv:LongFuturesContractsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 xdiv:LongFuturesContractsMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 xdiv:ShortFuturesContractsMember xdiv:USEquityExDividendFundSeries2027Member 2021-09-30 0001688487 xdiv:LongFuturesContractsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-09-30 0001688487 xdiv:LongFuturesContractsMember xdiv:USEquityExDividendFundSeries2027Member 2020-09-30 0001688487 xdiv:ShortFuturesContractsMember xdiv:USEquityExDividendFundSeries2027Member 2020-09-30 0001688487 xdiv:FuturesContractsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-09-30 0001688487 xdiv:FuturesContractsMember xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-12-31 0001688487 xdiv:FuturesContractsMember xdiv:EquityExDividendFundMember 2021-09-30 0001688487 xdiv:FuturesContractsMember xdiv:EquityExDividendFundMember 2020-12-31 0001688487 xdiv:DividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:ExDividendFundMember 2021-01-01 2021-09-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-06-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2021-07-01 2021-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2021-06-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2021-07-01 2021-09-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-06-30 0001688487 xdiv:USEquityCumulativeDividendsFundSeries2027Member 2020-07-01 2020-09-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2020-06-30 0001688487 xdiv:USEquityExDividendFundSeries2027Member 2020-07-01 2020-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Metaurus Equity Component Trust 10-Q